Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000687046 | SCV000814597 | likely benign | Spastic ataxia 2 | 2024-08-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003258918 | SCV003948639 | uncertain significance | Inborn genetic diseases | 2023-06-02 | criteria provided, single submitter | clinical testing | The c.682C>T (p.R228C) alteration is located in exon 8 (coding exon 6) of the KIF1C gene. This alteration results from a C to T substitution at nucleotide position 682, causing the arginine (R) at amino acid position 228 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Department of Pediatrics, |
RCV001252794 | SCV001163937 | uncertain significance | Microcephaly | no assertion criteria provided | research |